Chester County News and Community Website
HORSHAM, PA — Exegenesis Bio will supply its muscle-targeting AAV delivery technology to Modalis Therapeutics Corp. (TOKYO: 4883) under a research and licensing agreement aimed at advancing an experimental Duchenne …
Exegenesis Licenses AAV Capsid for Duchenne Therapy Push Read More
WILMINGTON, DE — AstraZeneca (NYSE: AZN) completed an exclusive licensing agreement for ZEGFROVY, gaining worldwide development and commercialization rights to the lung cancer drug in a deal that includes $600 …
AstraZeneca Secures ZEGFROVY Rights in Up to $1.5B Deal Read More
PHILADELPHIA, PA — Tolerance Bio Inc. licensed regional rights to NeoImmuneTech’s clinical-stage immune therapy efineptakin alfa in a deal carrying as much as $260 million in potential milestone payments, moving …
Tolerance Bio Licenses IL-7 Drug in Deal Worth Up to $260 Million Read More
PHILADELPHIA, PA — Datavault AI Inc. (Nasdaq: DVLT) expanded its technology licensing agreement with DataMeds AI Inc. (Nasdaq: MEDS) to cover commercial healthcare, healthspan and wellness applications, while restructuring its …
Datavault AI Expands Data Licensing Deal With DataMEDS Read More
WILMINGTON, DE — InterDigital Inc. (Nasdaq: IDCC) has expanded its patent licensing business into electric vehicle charging equipment through a new agreement with KEBA Energy Automation GmbH, extending the company’s …
InterDigital Broadens Patent Licensing With EV Charging Deal Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has granted Medomie Pharma Ltd. exclusive rights to seek regulatory approval and commercialize its skin disease treatment YCANTH in Israel, expanding …
Verrica Expands YCANTH Rights to Israel in Licensing Deal Read More
CHESTERBROOK, PA — Neuraptive Therapeutics has licensed a bioresorbable wireless nerve stimulation technology from Washington University in St. Louis, broadening its portfolio of therapies for peripheral nerve injuries as its …
Neuraptive Expands Nerve Repair Portfolio With Device License Read More
MALVERN, PA — Ocugen Inc. (NASDAQ: OCGN) has signed a binding term sheet that could generate up to $259 million in licensing and sales milestone payments, plus ongoing royalties, as …
Ocugen Targets $259 Million in MENA Licensing Deal for OCU400 Read More WILMINGTON, DE — InterDigital Inc. (Nasdaq: IDCC) has reached a patent licensing agreement with Amazon that covers the technology developer’s intellectual property portfolio across Amazon devices and services, including Prime …
InterDigital Reaches Amazon License Deal, Ends Patent Disputes Read More WILMINGTON, DE — InterDigital, Inc. (Nasdaq: IDCC) signed a new Internet of Things patent licensing agreement with an unnamed fintech company, extending the company’s monetization strategy beyond smartphones into connected …
InterDigital Expands IoT Licensing With Fintech Deal Read More